These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33719204)

  • 1. Quantitative systems pharmacology in neuroscience: Novel methodologies and technologies.
    Bloomingdale P; Karelina T; Cirit M; Muldoon SF; Baker J; McCarty WJ; Geerts H; Macha S
    CPT Pharmacometrics Syst Pharmacol; 2021 May; 10(5):412-419. PubMed ID: 33719204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hallmarks of neurodegenerative disease: A systems pharmacology perspective.
    Bloomingdale P; Karelina T; Ramakrishnan V; Bakshi S; Véronneau-Veilleux F; Moye M; Sekiguchi K; Meno-Tetang G; Mohan A; Maithreye R; Thomas VA; Gibbons F; Cabal A; Bouteiller JM; Geerts H
    CPT Pharmacometrics Syst Pharmacol; 2022 Nov; 11(11):1399-1429. PubMed ID: 35894182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The convergence of pharmacometrics and quantitative systems pharmacology in pharmaceutical research and development.
    Joshi A; Ramanujan S; Jin JY
    Eur J Pharm Sci; 2023 Mar; 182():106380. PubMed ID: 36638898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of pharmacometrics and quantitative systems pharmacology to cancer therapy: The example of luminal a breast cancer.
    Fleisher B; Brown AN; Ait-Oudhia S
    Pharmacol Res; 2017 Oct; 124():20-33. PubMed ID: 28735000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual Populations for Quantitative Systems Pharmacology Models.
    Cheng Y; Straube R; Alnaif AE; Huang L; Leil TA; Schmidt BJ
    Methods Mol Biol; 2022; 2486():129-179. PubMed ID: 35437722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges.
    Geerts H; Wikswo J; van der Graaf PH; Bai JPF; Gaiteri C; Bennett D; Swalley SE; Schuck E; Kaddurah-Daouk R; Tsaioun K; Pelleymounter M
    CPT Pharmacometrics Syst Pharmacol; 2020 Jan; 9(1):5-20. PubMed ID: 31674729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-disease modeling in the pharmaceutical industry - where mechanistic systems pharmacology and statistical pharmacometrics meet.
    Helmlinger G; Al-Huniti N; Aksenov S; Peskov K; Hallow KM; Chu L; Boulton D; Eriksson U; Hamrén B; Lambert C; Masson E; Tomkinson H; Stanski D
    Eur J Pharm Sci; 2017 Nov; 109S():S39-S46. PubMed ID: 28506868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing Human Microphysiology Systems as Key Experimental Models for Quantitative Systems Pharmacology.
    Taylor DL; Gough A; Schurdak ME; Vernetti L; Chennubhotla CS; Lefever D; Pei F; Faeder JR; Lezon TR; Stern AM; Bahar I
    Handb Exp Pharmacol; 2019; 260():327-367. PubMed ID: 31201557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilizing microphysiological systems and induced pluripotent stem cells for disease modeling: a case study for blood brain barrier research in a pharmaceutical setting.
    Fabre KM; Delsing L; Hicks R; Colclough N; Crowther DC; Ewart L
    Adv Drug Deliv Rev; 2019 Feb; 140():129-135. PubMed ID: 30253201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boolean network modeling in systems pharmacology.
    Bloomingdale P; Nguyen VA; Niu J; Mager DE
    J Pharmacokinet Pharmacodyn; 2018 Feb; 45(1):159-180. PubMed ID: 29307099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases.
    Hung SSC; Khan S; Lo CY; Hewitt AW; Wong RCB
    Pharmacol Ther; 2017 Sep; 177():32-43. PubMed ID: 28223228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodologies for Quantitative Systems Pharmacology (QSP) Models: Design and Estimation.
    Ribba B; Grimm HP; Agoram B; Davies MR; Gadkar K; Niederer S; van Riel N; Timmis J; van der Graaf PH
    CPT Pharmacometrics Syst Pharmacol; 2017 Aug; 6(8):496-498. PubMed ID: 28585415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Development for Neurodegenerative Diseases--Second Annual marcus evans Conference. Advances in drug development for NDD and expediting discovery through novel compounds and sound clinical trials.
    Morimoto B
    IDrugs; 2010 Jul; 13(7):440-3. PubMed ID: 20582866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of and insights from systems pharmacology models of antibody-drug conjugates.
    Lam I; Pilla Reddy V; Ball K; Arends RH; Mac Gabhann F
    CPT Pharmacometrics Syst Pharmacol; 2022 Aug; 11(8):967-990. PubMed ID: 35712824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D human brain cell models: New frontiers in disease understanding and drug discovery for neurodegenerative diseases.
    Korhonen P; Malm T; White AR
    Neurochem Int; 2018 Nov; 120():191-199. PubMed ID: 30176269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
    Corti S; Faravelli I; Cardano M; Conti L
    Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human pluripotent stem cell-derived models and drug screening in CNS precision medicine.
    Silva MC; Haggarty SJ
    Ann N Y Acad Sci; 2020 Jul; 1471(1):18-56. PubMed ID: 30875083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Labeled stem cells as disease models and in drug discovery.
    Ellerström C; Strehl R; Hyllner J
    Methods Mol Biol; 2013; 997():239-51. PubMed ID: 23546761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. History and Future Perspectives on the Discipline of Quantitative Systems Pharmacology Modeling and Its Applications.
    Azer K; Kaddi CD; Barrett JS; Bai JPF; McQuade ST; Merrill NJ; Piccoli B; Neves-Zaph S; Marchetti L; Lombardo R; Parolo S; Immanuel SRC; Baliga NS
    Front Physiol; 2021; 12():637999. PubMed ID: 33841175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards the virtual human patient. Quantitative Systems Pharmacology in Alzheimer's disease.
    Geerts H; Spiros A; Roberts P; Carr R
    Eur J Pharmacol; 2017 Dec; 817():38-45. PubMed ID: 28583429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.